drugset / Trial / NCT03780049
HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Hepatic artery infusion chemotherapy (HAIC) is effective and safe for hepatocellular carcinoma (HCC). Recombinant Human Type-5 Adenovirus (H101) is safe for HCC. The purpose of this study is to evaluate the efficacy and safety of HAIC combined with H101 compared with HAIC alone in patients with unresectable hepatocellular carcinoma (HCC) at barcelona clinic liver cancer A-B stage.
Timeline
- Start
- 2018-10-01
- Primary completion
- 2023-10-01
- Completion
- 2023-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | H101 | Other / unclassified | 0.5 ml | Other |